In contrast, Jung et al. found that low-dose apigenin intervention (0.005% apigenin in HFD) for 16 weeks in diet-induced obese C57BL/6J mice did not reduce body weight but improved lipid metabolism-related indicators such as plasma free fatty acids, TC, apolipoprotein B, and markers of liver dysfunction. Here, APOB is linked to Decreased liver function.